The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
It has been suggested that the metabolic enzyme indoleamine 2,3-dioxygenase (IDO) is a biological mediator of inflammation related to depressive disorders, with a Kynurenine (KYN) increase in the Tryptophan (TRP) metabolic pathway resulting in reduced Serotonin. In this study, we examined KYN, TRP, and the ratio of KYN to TRP concentrations × 103 (KT Ratio) in serum and cerebrospinal fluid (CSF) in a) depressed patients and b) a group of patients referred to a neurologic outpatient clinic for whom no specific diagnosis could be established. The KT Ratio is considered an index that represents IDO. The participants were examined with the Beck Depression Inventory II (BDI-II), the Montgomery Aasberg Depression Rating Scale (MADRS) and a neuropsychological test battery. We found no significant differences between the two study groups with respect to TRP, KYN or KT Ratio in serum or CSF. Differences in neuropsychological performance between the two patient groups could be seen in the following tests: Animal Fluency, Digit Symbol, WAIS-III, the D-KEFS Color-Interference Test (Naming Part), Trail Making Test A and B, and the Grooved Pegboard Non-dominant Hand. KYN in serum correlated highly with KYN in CSF, but did not correlate with TRP. KYN in serum correlated significantly with both age and gender. When analyzing males and females separately we found that women had a lower level of TRP in both serum (Mann-Whitney U-test: TRP in Serum; p = 0.001) and CSF (Mann-Whitney U-Test: TRP in CSF; p = 0.003). Women had a lower level of KYN in serum (p = 0.029) than men did. Age was positively associated with KYN. KYN in CSF however, correlated only with age; there were no gender differences. No significant association was seen between BDI-II and MADRS on the one hand, and KYN and TRP on the other. KYN in CSF as the KT Ratio in both serum and CSF was associated with neuropsychological performance. We suggest that KYN and KT Ratio are related more strongly to sickness behavior than to depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965
Alexopoulos, G. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66665-2 · Cited by 2,024
Hippocampal Volume Reduction in Major Depression
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670
Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998) · The Clinical Neuropsychologist · doi:10.1076/clin.12.1.43.1726 · Cited by 1,597 · cited 2×
“• Brief Visual Memory Test-R (BVMT) measures immediate and delayed visual recall (Benedict et al., 1998).”
MethodThe hopkins verbal learning test: Development of a new memory test with six equivalent forms
Brandt, J. (1991) · Clinical Neuropsychologist · doi:10.1080/13854049108403297 · Cited by 1,317 · cited 1×
“• Hopkins Verbal Learning Test-R (HVLT): immediate total recall and delayed recall (Brandt, 1991, 2001).”
BackgroundO'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278 · cited 1×
“It has been suggested that the metabolic enzyme indoleamine 2,3-dioxygenase (IDO) is a biological mediator of inflammation related to depressive disorders, as seen in animal models and after drug therapy in humans with interferon-α (O’Connor et al., 2009a,b; Raison et al., 2010).”
BackgroundCytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235 · cited 1×
“…Noradrenaline, there may be less regulation in neurotransmission related to these neurotransmitters in depression, with increased production of KYN (Schildkraut, 1965; Ressler and Nemeroff, 1999, 2000; Dursun et al., 2001; Bonaccorso et al., 2002; Capuron et al., 2002c, 2003; Castanon et al.,…”
BackgroundCapuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797
Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630 · cited 1×
“…may be less regulation in neurotransmission related to these neurotransmitters in depression, with increased production of KYN (Schildkraut, 1965; Ressler and Nemeroff, 1999, 2000; Dursun et al., 2001; Bonaccorso et al., 2002; Capuron et al., 2002c, 2003; Castanon et al., 2002; Wichers and Maes,…”
BackgroundMonitoring tryptophan metabolism in chronic immune activation
Schröcksnadel, K., Wirleitner, B., Winkler, C., & Fuchs, D. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.013 · Cited by 551 · cited 1×
“(b) Beck Depression Inventory II (BDI-II) (Beck et al., 1996; Steer et al., 1997, 1999) also yielded four categories: minimal depression 0–13, mild depression 14–19, moderate depression 20–28, and severe depression 29–63.”
MethodA preliminary profile of neuropsychological deficits associated with major depression
Veiel, H. O. F. (1997) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639708403745 · Cited by 502 · cited 1×
“Cognitive dysfunction is common in depression (Veiel, 1997; Gualtieri et al., 2006; Farup and Hestad, 2015).”
BackgroundGuillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · cited 1×
“In addition, IDO and TDO may activate depression through the metabolite 3-hydroxy-kynerunine (3OH-KYN) and quinolinic acid (QUIN) (Heyes et al., 1996; Guillemin et al., 2005).”
BackgroundInterferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473 · cited 3×
“…related to these neurotransmitters in depression, with increased production of KYN (Schildkraut, 1965; Ressler and Nemeroff, 1999, 2000; Dursun et al., 2001; Bonaccorso et al., 2002; Capuron et al., 2002c, 2003; Castanon et al., 2002; Wichers and Maes, 2004; Muller and Schwarz, 2006).”
BackgroundBonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., & Maes, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00014 · Cited by 437
A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder
Young, J. J., Bruno, D., & Pomara, N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.07.032 · Cited by 422
Role of norepinephrine in the pathophysiology and treatment of mood disorders
Ressler, K. J., & Nemeroff, C. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00127-4 · Cited by 307
Hestad, K. A., Tønseth, S., Støen, C. D., Ueland, T., & Aukrust, P. (2003) · The Journal of ECT · doi:10.1097/00124509-200312000-00002 · Cited by 235 · cited 1×
“These pathways, interacting with each other, provide a biological basis for the development of depression, and elevation of proinflammatory cytokines and other signs of inflammation are frequently seen (Hestad et al., 2003; Young et al., 2014; Poon et al., 2015).”
BackgroundSelf-citationGene expression in major depressive disorder
Jansen, R., Penninx, B. W. J. H., Madar, V, Xia, K., Milaneschi, Y., Hottenga, J. J., Hammerschlag, A. R., Beekman, A., van der Wee, N., Smit, J. H., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.57 · Cited by 224 · cited 1×
“Examining gene expression in major depression showed a significantly different regulation of inflammatory/immune pathways than exhibited by healthy controls (Jansen et al., 2015).”
BackgroundTreatment of cytokine-induced depression
Capuron, L., Hauser, P., Hinze-Selch, D., Miller, A. H., & Neveu, P. J. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00007-7 · Cited by 132
Hestad, K. A., Engedal, K., Whist, J. E., Aukrust, P., Farup, P. G., Mollnes, T. E., & Ueland, T. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s101925 · Cited by 42
Self-citation
Cited by
Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain
Gao, K., Mu, C.-L., Farzi, A., & Zhu, W.-Y. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz127 · Cited by 1,029
“Previous studies have revealed that decreased levels of tryptophan and an increased kynurenine to tryptophan ratio in the plasma are closely associated with depression (97, 98).”
BackgroundBrown, S. J., Christofides, K., Weissleder, C., Huang, X.-F., Shannon Weickert, C., Lim, C. K., & Newell, K. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01736-8 · Cited by 44
APOE polymorphism is associated with changes in the kynurenine pathway
Farup, P. G., Rootwelt, H., & Hestad, K. (2023) · Genes · doi:10.3390/genes14101955 · Cited by 1
Self-citation
Metadata
- Authors
- Hestad, K. A., Engedal, K., Whist, J. E., & Farup, P. G.
- Venue
- Frontiers in Psychology
- Publisher
- Frontiers Media SA
- Published
- 2017-10-04
- Volume
- 8
- Pages
- 1561-1561
- ISSN
- 1664-1078 (ISSN-L)
- OpenAlex
- W2764041992
- Cited by
- 72
- References
- 22
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.